INMED PHARMACEUTICALS INC (INM)       2.74  +0.05 (+1.86%)

2.74  +0.05 (+1.86%)

CA4576376012 - Common Stock - After market: 2.67 -0.07 (-2.55%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q4 2022 -14.03 -0.18 -13.85-7,617.27% Q3 2022 -6.25 -0.17 -6.08-3,540.07% Q2 2022 -7.75 -5.56 -2.20-39.51% Q1 2022 -6.25 -6.31 0.060.99% Q4 2021 -10.25 -5.93 -4.32-72.74% Q3 2021 -10.25 -8.84 -1.41-15.98% Q2 2021 -10.25 -8.59 -1.66-19.39% Q1 2021 -0.41 -6.06 5.6593.23%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2023 -0.50 -34.28 98.54%Q1 2023 -0.18 -6.25 97.09%Q2 2023 -0.17 -7.75 97.78%FY 2024 -0.45 -0.50 10.10%FY 2025 -0.69 -0.45 -52.55%FY 2026 -1.06 -0.69 -54.08%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q1 2023 320.79K 707K -386.21K-54.63% Q4 2022 514.76K 505K 9.76K1.93% Q3 2022 309.59K 505K -195.41K-38.70% Q2 2022 265.09K 757.5K -492.41K-65.00% Q1 2022 606K -606K-100.00% Q4 2021 126.25K -126.25K-100.00% Q3 2021 252.5K -252.5K-100.00% Q2 2021 %
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2023 5.05M 1.089M 363.54%Q2 2023 909K 265.09K 242.90%FY 2024 7.575M 5.05M 50.00%FY 2025 10.1M 7.575M 33.33%FY 2026 13.125M 10.1M 29.95%FY 2027 15.176M 13.125M 15.63%